Quotes by John LaMattina

“We recognize that many diseases we aim to treat have a strong genetic component. Additionally, we know some patients taking medicines show efficacy or experience side-effects, while others do not. Our understanding of all this has improved greatly but these areas remain as significant challenges in drug development.”

“We will be the first out there and for a while.”

“More than one billion people around the world suffer from neurological conditions and diseases, and finding new, more effective treatments for patients is a high priority for Pfizer research and development.”

“Is the public more cynical? Yes. Theres a perception that we dont bring much to the party.”

“Im a big believer in size, ... When youre a smaller company, as we were 27 years ago when I started, you dont necessarily have the resources to invest in things outside your immediate expertise. But as weve gotten bigger and become more resource-rich weve been able to expand.”

“Were of a size and can do enough different things that were not putting all our bets on one specific area,”

“I think this will be the norm. When you have something new, there is the theoretical potential for harm.”